Navigation Links
Helix BioPharma reports Q2 2008 highlights, financial results
Date:3/10/2008

sh used in operating activities totaled $1,073 and $1,330, respectively. The decrease in cash used in operating activities was mainly the result of lower costs associated with the Company's annual shareholder meeting held on January 29, 2008.

For the six month period ended January 31, 2008, cash used in operations was relatively unchanged compared to the six months ended January 31, 2007.

Financing activities

Financing activities in each of the three and six month periods ended January 31, 2008 were $14,614,000, compared to nil and $6,480,000, respectively, a year ago. All financing activities related to separate private placements in the given periods.

Investing activities

Use of cash in investing activities for the three and six month periods ended January 31, 2008, as well as the three month period ended a year ago, totaled $9,000, $59,000 and $11,000, respectively. For the six month period last year, investing activities were a source of cash totaling $6,614,000 of which $6,640,000 represented a redemption of short-term investments. Excluding the redemption of short-term investments, all use of funds in investing activities represented capital acquisitions in the particular period. When appropriate, the Company maintains excess funds in short-term investments and redeems these funds as required for its daily operating requirements.

LIQUIDITY AND CAPITAL RESOURCES

Since inception, the Company has financed its operations from public and private sales of equity, the exercise of warrants and stock options, interest income on funds available for investment, government grants, investment tax credits, and revenues from distribution, licensing and contract services. Because the Company does not have net earnings from its operations, the Company's long-term liquidity depends on its ability to access the capital markets, which depends substantially on the Company's ongoing research and development programs.

At Januar
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. Helix BioPharma shareholders vote in favour of management
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 2015 At the 11th hour, ... waved the shortfall of Jude Liversage,s campaign ... the first time.      (Photo: http://photos.prnewswire.com/prnh/20150803/254228 ... ) The Selective Dorsal Rhizotomy (SDR) procedure ... carry out his wish to kick a ball around ...
(Date:8/3/2015)... UK (PRWEB) , ... August 03, 2015 , ... ... consumer of benzene. Benzene is processed to get such derivatives as ethylbenzene, a ... derivatives are principally used within the automotive industry for the production of tyres ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Nine field ... Iowa, Illinois and Indiana. Hosted by the Soil Health Partnership , the field ... lasting environmental benefits while potentially increasing farm productivity and income. , Brent Bible has ...
(Date:8/3/2015)... , August 3, 2015 ... the commercialization of its Bio-electrical Signal Therapy device ("BST ... treatment of hard to heal chronic wounds, today announced ... with Chemipal, an Israeli distributor specializing in medical devices, ... Chemipal is a 70 years old, sales, ...
Breaking Biology Technology:Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 2World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 3Soil Health Field Days Kick Off Throughout Midwest 2Soil Health Field Days Kick Off Throughout Midwest 3E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3
... 1 Sidec announces the first,Protein Tomography(TM) ... This Award,is set up to enable research ... yet collaborated with Sidec on a Protein ... technology successfully used in,cancer drug research., ...
... Highlights 140 Doctors Changing the Face of ... ... of BLACK ENTERPRISE (BE),unveils its 2008 report on the best and brightest ... millions of lives through the revolutionary treatment of,diseases, from cancer and diabetes ...
... CryoLife, Inc., (NYSE: CRY ) a,biomaterials, ... Harvey Morgan has been elected to the Company,s ... Managing Director at Bentley,Associates L.P., an investment banking ... years of investment banking experience with,significant expertise in ...
Cached Biology Technology:Sidec Announces the First Protein Tomography(TM) Award at Sidec's Executive Forum at PEGS 2Black Enterprise Unveils America's Leading Doctors 2Black Enterprise Unveils America's Leading Doctors 3Harvey Morgan Joins CryoLife Board of Directors 2
(Date:7/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), a leading developer ... report financial results for the fourth quarter and fiscal ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-455-2260 (conference ...
(Date:7/8/2015)... NEW YORK , July 8, 2015 ... today announced BD & Guidepoint Mentor, ... free access to Guidepoint,s expert network services. ... developing cutting-edge technologies to improve healthcare delivery and outcomes ... manager, each start-up entrepreneur will be able to directly ...
(Date:7/7/2015)... Conn. , July 7, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces a revised version ... this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the cards ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... of drugs commonly used to treat diabetes can double the ... study by the University of East Anglia (UEA) and Wake ... Association Journal (CMAJ) , the findings show that use of ... 2 diabetes significantly reduces bone density, resulting in the risk ...
... a mental illness are more likely to suffer episodes of ... analyzed four decades of data. Additionally, they found people ... live near that brother or sister but be somewhat ... in the December issue of the Journal of Family ...
... everybody to be like them? Yes, Wii can. ... Science Foundation (NSF) is making use of Nintendo,s popular video ... be used in a range of human endeavors, from sports ... Byrne, are following up on O,Malley,s pioneering work using robots ...
Cached Biology News:Long-term use of diabetes drugs by women significantly increases risk of fractures 2Siblings of mentally disabled face own lifelong challenges, according to researchers 2Wii bit of fun at Rice University has serious intent 2
BD IMagnet 1 each...
MHC. Sections include: the isolation and functional properties of antigen-presenting cells analysis of MHC class II endocytosis and peptide turnover analysis of signalling via MHC class II molecu...
Thermal Printer Paper for Monolight(tm) Luminometer 1 each...
Ultra-sensitive, non-radioactive detection of rat Big Endothelin-1 (Big ET-1)...
Biology Products: